General Adult PopulationTYDQ-15NCT06908525
Norwegian Translation of the Things You Do Questionnaire 15-Item Version
An observational study of General Adult Population and Age 16 and Older, run by Haukeland University Hospital.
Trial summary
Psychotherapy aims to modify dysfunctional patterns of thinking, feeling, and behaving to improve mental health. A five-factor model of adaptive behaviors, operationalized in the Things You Do Questionnaire (TYDQ), has been identified as a mediator of treatment response in depression and anxiety interventions. Read more about this study
- Who is it for?
- Ages 16 to 100 yearsHealthy volunteers can take part
- Conditions the study is for
- General Adult Population, Age 16 and Older
- How many people
- 1,000 participants
- Where
- No sites listed yet
- Study dates
- 24 Mar 2025to 1 Feb 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 16 to 100 years
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: General population of Norway
Who may be able to join
- Age > 16 years
- Native Norwegian speaker
Who cannot join
- Does not speak Norwegian fluently
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: A Translation Study of the Things You Do Questionnaire 15-Item Version
Psychotherapy aims to modify dysfunctional patterns of thinking, feeling, and behaving to improve mental health. A five-factor model of adaptive behaviors, operationalized in the Things You Do Questionnaire (TYDQ), has been identified as a mediator of treatment response in depression and anxiety interventions. The short-form TYDQ-15 is a key component of a transdiagnostic treatment promoting adaptive behavior. To implement this intervention in Norway, the TYDQ-15 requires translation and cultural adaptation, following established guidelines for clinical assessment instruments. Currently unavailable in Norwegian, its translation and psychometric evaluation are necessary for clinical application. This study aims to (1) produce a culturally adapted Norwegian version of the TYDQ-15 and (2) assess its psychometric properties, including reliability, factor structure, and criterion validity, within a Norwegian population. The findings will facilitate the integration of the Things You Do Intervention into Norwegian mental health services.
- Conditions
- General Adult Population, Age 16 and Older
- Keywords
- Translation, TYDQ-15, Psychometric Evaluation
What is being measured
The primary outcome is the main question the study is designed to answer.
Things You Do Questionnaire 15-Item Version (TYDQ-15)
The Things You Do Questionnaire - 15 Item Version (TYDQ-15) measures how frequently one engages in adaptive behavior with 15 items scored 0 ("never") to 4 ("every day"). The 15 items are grouped into the five domains of "meaningful activities", "healthy thinking", "goals and plans", "healthy routines", and "social connections. The original English language instrument has been shown to have acceptable psychometric properties across representative population samples.
Measured: Singe time point, at enrolment.
Secondary outcomes (3)
The Patient Health Questionnaire (PHQ-9)
The Patient Health Questionnaire (PHQ-9) - measures depression severity with nine items scored 0 ("not at all") to 3 ("nearly every day"), corresponding to the criteria for major depression in the DSM-5. The sum of the nine items ranges from 0-27. The scale has demonstrated adequate psychometric properties across different samples and has been found to be sensitive to change in depressive symptoms.
Measured: Single time point, at enrolment.
The Generalized Anxiety Disorder Scale (GAD-7)
The Generalized Anxiety Disorder Scale (GAD-7) - measures anxiety severity with seven items scored 0 ("not at all") to 3 ("nearly every day") corresponding to symptoms of anxiety disorders. The sum score ranges from 0-21. GAD-7 has demonstrated adequate psychometric properties across different samples and has been found to be sensitive to the presence of anxiety disorders.
Measured: Single time point, at enrolment.
The Satisfaction with Life Scale (SWLS)
The Satisfaction with Life Scale (SWLS) - measures life-satisfaction with 5 items scored 1 ("strongly disagree") to 7 ("strongly agree"), corresponding to statements of general life satisfaction. Sum scores range from X to Y with higher scores indicating greater life satisfaction. The SWLS has demonstrated adequate psychometric properties across different samples.
Measured: Single time point, at enrolment.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Apr 2025
- Study start24 Mar 2025 (estimated)
- Primary completion1 Apr 2026 (estimated)
- Study completion1 Feb 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for General Adult PopulationStudies of the same condition, open and under way.
- More trials run by Haukeland University HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Ecologic or community
- Time perspective
- Cross-sectional
- Enrolment
- 1,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Haukeland University Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Aleksander Gulla Heltne, Haukeland University Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06908525
- Sponsor's protocol ID
- 897112
- Other IDs
- 309264
- Acronym
- TYDQ-15
- Status last verified
- Mar 2025
- First submitted
- 19 Mar 2025
- Last updated
- 3 Apr 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided: The sharing of IPD for this study will require guaranteed anonymity for all involved participants. Unless such anonymity can be guaranteed, IPD will not be shared outside the research team. Current advances in machine learning and AI introduce difficult questions regarding the possibility of re-identification of research participants from patterns in the data. Decisions of IPD publication therefore require additional consideration.
Study at a glance
From the registry record, last updated by the sponsor on 3 Apr 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Translation Study of the Things You Do Questionnaire 15-Item Version
- ClinicalTrials.gov ID
- NCT06908525
- Acronym / sponsor ID
- TYDQ-15 / 897112
- Conditions
- General Adult Population, Age 16 and Older
- Keywords
- Translation, TYDQ-15, Psychometric Evaluation
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 1,000 participants (estimated)
- Lead sponsor
- Haukeland University HospitalUniversity, hospital or other
- Study start
- 24 Mar 2025 (estimated)
- Primary completion
- 1 Apr 2026 (estimated)
- Study completion
- 1 Feb 2027 (estimated)
- First posted
- 3 Apr 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Psychotherapy aims to modify dysfunctional patterns of thinking, feeling, and behaving to improve mental health. A five-factor model of adaptive behaviors, operationalized in the Things You Do Questionnaire (TYDQ), has been identified as a mediator of treatment response in depression and anxiety interventions. The short-form TYDQ-15 is a key component of a transdiagnostic treatment promoting adaptive behavior. To implement this intervention in Norway, the TYDQ-15 requires translation and cultural adaptation, following established guidelines for clinical assessment instruments. Currently unavailable in Norwegian, its translation and psychometric evaluation are necessary for clinical application. This study aims to (1) produce a culturally adapted Norwegian version of the TYDQ-15 and (2) assess its psychometric properties, including reliability, factor structure, and criterion validity, within a Norwegian population. The findings will facilitate the integration of the Things You Do Intervention into Norwegian mental health services.
Study design
- Observational model
- Ecologic or community
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 16 to 100 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- General population of Norway
Key inclusion criteria (2 listed)
- Age > 16 years
- Native Norwegian speaker
Key exclusion criteria (1 listed)
- Does not speak Norwegian fluently
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Things You Do Questionnaire 15-Item Version (TYDQ-15)
Time frame: Singe time point, at enrolment.
The Things You Do Questionnaire - 15 Item Version (TYDQ-15) measures how frequently one engages in adaptive behavior with 15 items scored 0 ("never") to 4 ("every day"). The 15 items are grouped into the five domains of "meaningful activities", "healthy thinking", "goals and plans", "healthy routines", and "social connections. The original English language instrument has been shown to have acceptable psychometric properties across representative population samples.
3 secondary outcomes
The Patient Health Questionnaire (PHQ-9)
Time frame: Single time point, at enrolment.
The Generalized Anxiety Disorder Scale (GAD-7)
Time frame: Single time point, at enrolment.
The Satisfaction with Life Scale (SWLS)
Time frame: Single time point, at enrolment.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Apr 2025.
- Individual participant dataSharing planned: Undecided. The sharing of IPD for this study will require guaranteed anonymity for all involved participants. Unless such anonymity can be guaranteed, IPD will not be shared outside the research team. Current advances in machine learning and AI introduce difficult questions regarding the possibility of re-identification of research participants from patterns in the data. Decisions of IPD publication therefore require additional consideration.
Related trials for General Adult Population
Not yet recruiting
CannaRiver CBD Calm for Anxiety, Sleep, and Well-Being in Adults With Generalized Anxiety Disorder
Generalized Anxiety Disorder
Active, not recruiting
PREWELL Digital Well-being Promotion Intervention With the BitHabit App
General Mental Health and Well-Being, Mental Disorders
RecruitingPhase 3
A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With Generalized Anxiety Disorder
Generalized Anxiety Disorder
RecruitingPhase 3
A Trial of the Efficacy and Safety of a Fixed Dose of SEP-363856 in Adults With Generalized Anxiety Disorder
Generalized Anxiety Disorder
Active, not recruitingPhase 3
Phase 3b Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib in Comparison to Placebo, With Omalizumab as Active Control, in Adult CSU Patients, Followed by an Open-label 52-week Optional Extension.
Chronic Spontaneous Urticaria
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Questions about this trial
What is this clinical trial studying?
An observational study of General Adult Population and Age 16 and Older, run by Haukeland University Hospital.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 3 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Aleksander G Heltne, PhD (00000000 ext. 0047, aleksander.gulla.heltne@helse-bergen.no), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Things You Do Questionnaire 15-Item Version (TYDQ-15) (time frame: Singe time point, at enrolment.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Apr 2025.